Search

Search Funnelback University

Search powered by Funnelback
Your query has been expanded to download |u:www.enterprize.cam.ac.uk.  Search for download |u:www.enterprise.cam.ac.uk instead.
21 - 40 of 62 search results for download |u:www.enterprise.cam.ac.uk or download |u:www.enterprize.cam.ac.uk
  1. Fully-matching results

  2. Marketing sheet revised version_28 Nov 18 JF.pub

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2018/11/Collagen-membranes-information-sheet.pdf
    28 Nov 2018: A new class of Collagen Membranes. For further information please contact: Dr Jennie Flint jennie.flint@enterprise.cam.ac.uk. 44 (0)1223 765035. Cambridge Enterprise Limited, University of Cambridge Hauser Forum, 3 Charles Babbage Road. Cambridge,
  3. Name of Invention

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2020/12/Marketing-Sheet-Collagen-Tubes-Mar-3702-18.pdf
    7 Dec 2020: Brief description Case Ref: XXX-XXXX-XX. www.enterprise.cam.ac.uk. For further information please contact:. The problem – unsuitable materials Synthetic material grafts do not imitate the extracellular niche, have limited or no bioactivity,
  4. Biophonics

    https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=25018
    1 Jul 2024: Biophonics. Biophonics. ENABLING WIDESPREAD EARLY DETECTIONOF VALVULAR HEART DISEASE WITH AUNIQUE MEDICAL DEVICE. Website. Overview. Nearly 2 million people in the UK suffer from significant valvular heart disease, yetmore than half remain
  5. ICM+

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2011/09/2021-09-25_Smi-833-03__ICM_Marketing-Sheet-FINAL.pdf
    30 Sep 2021: Brief description Case Ref: XXX-XXXX-XX. www.enterprise.cam.ac.uk. For further information please contact:. ICM+, developed by Dr Peter Smielewski and Prof Marek Czosnyka is a clinical research software for simultaneous and real-time multimodality
  6. Microsoft PowerPoint - InformationSheet-FlexibleMandrelFreeSpinning…

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2021/07/InformationSheet-FlexibleMandrelFreeSpinning-All-2449-10.pdf
    5 Jul 2021: Brief description Case Ref: XXX-XXXX-XX. www.enterprise.cam.ac.uk. For further information please contact:. Step change productivity in spinning: no mandrel, geometry control, asymmetryMetal spinning is used to manufacture high-value parts to
  7. Enabling High Data Rates-Pen-7846-20

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2021/07/Information-sheet-Enabling-High-Data-Rates-Pen-7846-20.pdf
    14 Jul 2021: Brief description Case Ref: XXX-XXXX-XX. www.enterprise.cam.ac.uk. For further information please contact:. New linearization methodConventional PAM-4. Enabling high data rate optical communications with directly-modulated lasers. The problem -
  8. Redox flow SOC measurement information sheet (Gre-7712-20)

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2021/11/Redox-flow-SOC-measurement-information-sheet-Gre-7712-20.pdf
    9 Mar 2022: Brief description Case Ref: XXX-XXXX-XX. www.enterprise.cam.ac.uk. For further information please contact:. The problem – measuring state-of-charge (SOC) using present techniques is unreliable. Knowledge of SOC in electrolyte reservoirs in redox
  9. NMC coating information sheet (Gre-7694-20)

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2022/03/NMC-coating-information-sheet-Gre-7694-20.pdf
    9 Feb 2022: Brief description Case Ref: XXX-XXXX-XX. www.enterprise.cam.ac.uk. For further information please contact:. The problem – degradation of NMC-811 cathodes is a major cause of capacity fade in modern Li-ion cells, and is therefore a bottleneck in
  10. 360° implant to treat spinal cord injuries

    https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=26299
    1 Jul 2024: 360 implant to treat spinal cord injuries. BACKGROUND. The spinal cord is a key organ of the nervous system, which is in charge of carryinginformation around the body. Every year between 250,000-500,000 people sufferinjuries to the spinal cord
  11. MutREAD – Mutational Signature Detection by Restriction…

    https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=23223
    1 Jul 2024: MutREAD – Mutational Signature Detection byRestriction Enzyme-Associated DNA Sequencing. BACKGROUND. The successful application of mutational signatures in clinical settingsrequires availability of a cost-effective, scalable detection method that
  12. PowerPoint Presentation

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2021/08/Deep-neural-network-for-perceived-loudness-calculation_Marketing-Sheet-Moo-3793-19-final.pdf
    18 Aug 2021: Brief description Case Ref: XXX-XXXX-XX. www.enterprise.cam.ac.uk. For further information please contact:. The problem – perceived loudness models are computationally expensive and slowThe loudness of a sound perceived by a human listener
  13. PredictImmune

    https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=24604
    1 Jul 2024: PredictImmune. PredictImmune. HELPING PATIENTS DIAGNOSED WITHCHRONIC IMMUNE-MEDIATED DISORDERS TOLIVE NORMAL AND HEALTHY LIVES. Website. Overview. PredictImmune developes prognostic assays that predict disease progression forpatients with
  14. Neonatal wireless transmission system

    https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=26298
    1 Jul 2024: Neonatal wireless transmission system. BACKGROUND. When babies are in intensive care, they need to be continuously monitored. Thisrequires multiple sensors with separate wires. These wires can become tangledand make clinical care harder. Parents
  15. Real-time autofocus for videomicroscopy

    https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=26290
    1 Jul 2024: Real-time autofocus for videomicroscopy. BACKGROUND. Video-microscopy of living subjects is hampered by their movement out of themicroscope’s focal plane. At video frame-rates, manual refocusing becomesimpossible; therefore, autofocus is required.
  16. Low-Cost Trace Analyte Detection with Reusable SERS Substrates

    https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=27187
    1 Jul 2024: Low-Cost Trace Analyte Detection with ReusableSERS Substrates. BACKGROUND. To move beyond current low-cost sensors, towards measuring trace analytes inapplications such as healthcare monitoring, geology and mineralogy, pollutionmonitoring, and
  17. Mouse Models of Essential Thrombocythemia (ET) and Myelofibrosis (MF) …

    https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=23888
    1 Jul 2024: Mouse Models of Essential Thrombocythemia(ET) and Myelofibrosis (MF) – Available forPreclinical Studies? Background. Researchers at the University of Cambridge have generated fully characterised,conditional knock-in mouse models for essential
  18. Name of Invention

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2020/12/Marketing-Sheet-Flexible-Ring-Rolling-All-3115-15.pdf
    3 Dec 2020: Brief description Case Ref: XXX-XXXX-XX. www.enterprise.cam.ac.uk. For further information please contact:. Step change in productivity for making profiled rings. Seamless ring components used in rotating machinery and fluid transfer applications
  19. Ortho-quinone prodrug strategy (self-immolative linkers)

    https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=23187
    1 Jul 2024: Ortho-quinone prodrug strategy (self-immolativelinkers). BACKGROUND. The para-quinones doxorubicin (Adriamycin),geldanamycin, mitoxantrone and mitomycin C have lowerredox-cycling rates than ortho-quinones and aresuccessfully used in the clinic.
  20. Microsoft PowerPoint - mor-2564-11 Marketing sheet May 2018 Final-nwm

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2014/06/mor-2564-11-Marketing-sheet-May-2018-Final-nwm-1.pdf
    3 Oct 2019: Name of inventionBrief description. Case Ref: Mor-2564-11. • EPCs are easily available from small volumes of peripheral blood (20-40 mL in adults) and rapidly expandable in culture. • They offer 95% efficiency for reprogramming into iPSCs with
  21. Implantable drug delivery device targeting brain tumours

    https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=26296
    1 Jul 2024: Implantable drug delivery device targeting braintumours. BACKGROUND. Successful treatment of brain cancers is limited due to the difficulty of deliveringtherapies to difficult-to-access tumours. There is also a need for new technologiesable to

Search history

Recently clicked results

Recently clicked results

Your click history is empty.

Recent searches

Recent searches

Your search history is empty.